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ABSTRACT
The aim of the present work was to study the biological behavior of a mouse mesenchymal stem cell line
when seeded and cultured under osteogenic conditions onto novel processed melt-based chitosan scaffolds.
Scaffolds were produced by compressionmolding, followed by salt leaching. Scanning electronmicroscopy
(SEM) observations and lCT analysis showed the pore sizes ranging between 250 and 500lm and the
interconnectivity of the porous structure. The chitosan–poly(butylenes succinate) scaffolds presented high
mechanical properties, similar to the ones of trabecular bone (E1%*75MPa). Cytotoxicity assays were
carried out using standard tests (accordingly to ISO/EN 10993 part 5 guidelines), namely, MTS test with a
24 h extraction period, revealing that L929 cells had similar metabolic activities to that obtained for the
negative control. Cell culture studies were conducted using a mouse mesenchymal stem cell line (BMC9).
Cells were seeded onto the scaffold and allowed to proliferate for 3 weeks under osteogenic conditions.
SEM observations demonstrated that cells were able to proliferate and massively colonize the scaffolds
structure. The cell viability assayMTS demonstrated that BMC9 cells were viable after 3 weeks of culture.
The cells clearly evidenced a positive differentiation toward the osteogenic lineage, as confirmed by the
high ALP activity levels.Moreover, energy dispersive spectroscopy (EDS) analysis revealed the presence of
Ca and P in the elaborated extracellular matrix (ECM). These combined results indicate that the novel
melt-based chitosan/polyester scaffolds support the adhesion, proliferation, and osteogenic differentiation
of the mouse MSCs and shows adequate physicochemical and biological properties for being used as
scaffolds in bone tissue engineering–related strategies.
INTRODUCTION
THE LAST 15 YEARS HAVE WITNESSED the emergence of anovel multidisciplinary field of science called tissue
engineering that has been in the forefront of a new wave of
therapeutic/regenerative approaches for a variety of tissues,
including bone. Its main purposes are production of tissues
and organs substitutes/equivalents that can replace or re-
store the natural features and physiological functions of
natural tissues in vivo.1,2
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The most common approach used in the bone tissue en-
gineering field is based on the seeding of cells with osteogenic
potential, commonly mesenchymal stem cells, on 3D scaf-
folds followed either by direct implantation on the injury
site or by an in vitro culturing period upon which the cells/
scaffold construct is implanted.3 Ultimately, these so-called
bone tissue engineering constructs should have two main
functions when implanted in vivo4–6: (1) provide structural
support until the neotissue can assure it by itself and (2)
promote osteoinduction, meaning, in a simplistic way, the
promotion of migration and differentiation of mesenchymal
stem and osteoprogenitor cells, which later will lead to new
bone formation. From the lines above, it can be clearly con-
cluded that 3D scaffolds play a major role within any bone
tissue engineering concept. Ideally these temporary scaffolds
should be porous in order to accommodate cell growth and
facilitate both tissue regeneration and vascularization.1,2,7
Further, they should also be biocompatible, be mechanically
stable under loads, and have a physiologic biodegradation
rate similar to the cell/tissue growth rates.1,2,7,8
Up to now, several materials, such as titanium alloys,9–11
ceramics,12–14 and biodegradable polymers,15–18 have been
used to obtain these 3D structures. Among those materials
and due to their intrinsic characteristics, biodegradable poly-
mers are those that have been used more frequently. The
most widely used are poly(a-hydroxy acids), such as poly
(lactic acid), poly(glycolic acid), and their copolymers, be-
cause they have been already accepted by regulatory agen-
cies. In spite of the fact that these materials have been
thoroughly studied and extensively used in the clinical prac-
tice, it is also true that upon degradation they release acidic
by-products, which may trigger inflammatory responses and
compromise the needed integration by the host tissue.19,20
Therefore, there is an urgent need for the development of
new biomaterials with scaffolding potential for bone tissue
engineering. It is in this context that natural-based polymers
have been put forward in the last few years.Within this group,
the polysaccharides, like starch,20–22 and chitosan,23–29 have
been highlighted as the most promising, as they may act as
analogs of polysaccharides present in vivo and adopt their
roles.27 An example of such affinity is the structural similarity
observed between chitosan and glycosaminoglycans.28 Sev-
eral reports about chitosan,23–29 the alkaline deacetylated
product of chitin, have shown that this polymer might have
a range of interesting properties, from biodegradability to
biocompatibility, considered to be suitable for bone tissue
engineering scaffolding. Nevertheless, chitosan still presents
a challenge when compared to other materials, that is, the
inability of being processed by means other than by solvent-
based technology, which frequently leads to the development
of scaffolds with poor mechanical properties and insufficient
control of its morphology.
Since 2005, we have developed a new concept based on
the development of thermoplastic chitosan polymers.30–33
This was achieved by melt-blending chitosan with different
aliphatic polyesters, poly(caprolactone) (PCL), poly(butyl-
enes succinate) (PBS), poly(butylene terephthalate adipate)
(PBTA), and poly(butylene succinate adipate) (PBSA). By
doing this, we conjugated the favorable biological properties
of chitosan with the predictable degradative behavior of the
aliphatic polyesters. Further information on the physical and
chemical properties of these materials can be found in the
reports of Correlo et al.30–33
The present study reports on the morphology, mechanical
properties, cytocompatibility, cell proliferation, and osteo-
genicdifferentiationofamesenchymal stemcell line (BMC9)
on novel compression molding/salt leaching scaffolds based
on blends of chitosan with PCL, PBS, PBTA, and PBSA.
Results have showed that the developed scaffolds had the
adequate mechanical properties. Further, they disclosed a
noncytotoxic behavior and simultaneously supported the
growth and osteogenic differentiation of mouse mesenchy-
mal stem cells within its structure.
MATERIALS AND METHODS
Scaffolds production and processing
Chitosan was melt blended with several biodegradable
polyesters for the first time by our group30 using a twin screw
extruder with the purpose of producing scaffolds for tissue
engineering applications. For the development of this work,
the polyesters compounded with chitosan were PBS, PCL,
and PBTA. In all of these blends there was a rate of 50%
(wt.%) chitosan with 50% (wt.%) polyester.
The methodology used for the scaffolds production was
melt-based compression molding followed by salt leaching.
The details of the processing conditions are described else-
where.33 Briefly, the developed blends were grained and the
powder mixed with salt particles with size 250 mm< d<
500 mm. The chitosan-based blends mixed with salt were
loaded into a mold that was further heated and compression
molded into discs. The salt content was 60% by weight. The
discs were cut into 5!5!5mm3 cubes. These cubes were
then immersed in distilled water to leach out the salt, dried,
sterilized by ethylene oxide, and used for cell culture studies.
Scaffolds characterization
The cross section of all the developed scaffolds was an-
alyzed using a Leica-Cambridge S-360 scanning electron
microscope (SEM) for preliminary assessment on the scaf-
folds morphology. All the samples were sputter-coated with
gold prior to SEM observations.
To investigate the internal 3D structure of the scaffolds,
Micro-Computed Tomography equipment (SkyScan, Kon-
tich, Belgium) was used as a nondestructive technique. Four
scaffolds of each condition were scanned in a high-resolu-
tion mode of 8.7 mm x/y/z and an exposure time of 1792ms.
The energy of the scanner used was 63 keV with 157 mA
current. mCT scans followed by 3D reconstruction of serial
image sections allowed to analyze 3D microarchitecture of
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the scaffolds, pore morphology, and the determination of
the porosity.
Uniaxial compression tests were performed on a square
cross-section specimen of scaffolds using a Universal ten-
sile testing machine (Instron 4505 Universal Machine). A
crosshead speed of 2mm/min was used. The values reported
were the average of at least five specimens. The compressive
modulus was determined by selecting the linear region of
the stress–strain graph.
Cell culture. A fibroblast cell line of rat lung—L929,
acquired from the European Collection of Cell Cultures
(ECACC), was used for cytotoxicity tests. The cells were
grown as monolayers in Dulbecco’s modified Eagle’s me-
dium (DMEM; Sigma, St. Louis, MO) supplemented with
10% foetal bovine serum (FBS; Biochrom, Berlin, Ger-
many) and 1% of antibiotic–antimycotic mixture (10,000U/
mL penicillin G sodium; 10,000U/mL streptomycin sulfate;
25 mg/mL amphotericin B) (Gibco, Invitrogen, Grand Island,
NY). Trypsin/EDTA (0.25%, w/v, trypsin/0.02% EDTA,
Sigma) was used to detach the cells from the culture flasks
before the experiments were conducted.
Cell viability assay—MTS test. The ratio of material
weight to extract fluid was constant, and equal to 0.25 g/mL.
Latex rubber and standard culture medium were used as
positive and negative controls, respectively. Latex rubber is
known to have a strong cytotoxic effect leading to extensive
cell death. For the positive control, the ratio of material outer
surface to extraction fluid was 2.5 cm2/mL. Test material
(n¼ 6) and positive control were extracted for 24 h at 378C,
using complete culture medium as extraction fluid. Before
the tests, culture medium was removed and an identical
volume (200 mL) of extraction fluid was added to each well.
Cells were seeded in 96-well plates (n¼ 6) at a density of
1.8!104 cells/well and incubated for 24 h at 378C, in a hu-
midified atmosphere with 5% CO2. A kit (CellTiter 96 One
solutionCell ProliferationAssay kit; Promega,Madison,WI)
was used, and it is based on the reduction of the substrate, 3-
(4,5-dimethylthiazol-2-yl)-5(3-carboxymethoxyphenyl)-2(4-
sulfofenyl)-2H-tetrazolium (MTS), into a brown formazan
product by dehydrogenase enzymes active in the viable cells.
After 72 h, the extraction fluid was removed, and 200mL of
a serum-free culture mediumwithout phenol red andMTS, in
a proportion of 5:1, was added to each well. Cells were then
incubated for 3 h at 378C in a humidified atmosphere contain-
ing 5% CO2. After this time, optical density (OD) was mea-
sured with a plate reader (Bio-tek, model Synergy HTi,
Winooski, VT) at 490 nm. TheOD values obtained were stan-
dardized taking intoaccount thevalues for thenegativecontrol.
Cell culture studies
Cell seeding and culture. A mouse mesenchymal stem
cell line (BMC9) was used. This conditionally immortal-
ized MPC clone was shown to exhibit four mesenchymal
cell phenotypes: chondrocyte, adipocyte, stromal (support
osteoclast formation), and osteoblast.34 The cells were grown
as monolayer cultures in a culture medium consisting of
DMEM medium, 10% FBS, and 1% antibiotic/antimycotic
mixture. When the adequate cell number was obtained, cells
at passage 10 were trypsinized, centrifuged, and resuspended
in cell culture medium. Cells were seeded at a density of
5!105 cells/scaffold under static conditions, using for this
purpose aliquots of 10mL loaded on the top of scaffolds. Two
hours after seeding, 1mL of culture medium was added to
each well. The cell-seeded scaffolds were maintained in
a humidified atmosphere at 378C, containing 5% CO2, under
osteogenic differentiation inducing medium, during 21 days.
The culture medium consisted of DMEMwithout phenol red,
dexamethasone 10#8M (Sigma), ascorbic acid 50mg/mL
(Sigma), and b-glycerophosphate 10mm (Sigma), and was
changed every 3–4 days until the end of the experiment.
Cellular viability assay—MTS test. Cell viability was
assessed after 3 h and 7, 14, and 21 days, by using the MTS
test. The cell-seeded scaffolds (n¼ 6) were rinsed in 0.15M
phosphate buffered saline (Sigma) and immersed in a mix-
ture consisting of serum-free cell culture medium and MTS
reagent at 5:1 ratio and incubated for 3 h at 378C in a hu-
midified atmosphere containing 5% CO2. After this, 200 mL
(n¼ 6) was transferred to 96-well plates and the optical
density (OD) determined at 490 nm.
Cell adhesion and morphology by SEM. Cell adhesion,
morphology,andaveragedistributionwereobservedbySEM.
The cell-seeded scaffolds were washed in 0.15M phosphate
buffered saline and fixed in 2.5% glutaraldehyde in phos-
phate buffered saline.
After rinsing three times in phosphate buffered saline, the
constructs were dehydrated using a series of graded ethyl
alcohols (30, 50, 70, 90, and 100% ethanol) for 15min each,
twice. Then, the samples were subjected to two changes for
15min each with 100% hexamethyldisilazane (HDMS;
Electron Microscopy Sciences, Fort Washington, PA). Fi-
nally HDMS was removed and let to air dry for 2 h. After-
ward, the constructs were sputter coated with gold ( JEOL
JFC-1100) and analyzed with a Leica Cambridge S360
scanning electron microscope.
Cell adhesion and cell viability by calcein AM staining
through confocal laser microscopy. Cells were incubated
with calcein AM (Molecular Probes, Invitrogen). Once in-
side the cells, this compound is hydrolyzed by endogenous
esterase into the highly negatively charged green fluorescent
calcein, which is retained in the cytoplasm. The cell-seeded
scaffolds were sectioned and cell adhesion, and viability was
observed in the inner regions of the scaffolds using an
Olympus FluoView FV1000 confocal laser microscope.
Histology. Eight-micrometer-thick sections from the 3-
week culture of scaffold–cell constructs were cut with a
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cryomicrotome (CM 1900; Leica, Bensheim, Germany) and
mounted on poly-L-lysine (Sigma)–coated slides. Slideswere
stained with H&E and observed under optical microscope.
Alkaline phosphatase quantification. A description of the
assay can be found elsewhere.35 Briefly, the level of alkaline
phosphatase (ALP) activity from the scaffolds/cells con-
structs (n¼ 3) was quantified by the specific conversion of p-
nitrophenyl phosphate (pNPP) (Sigma) into p-nitrophenol
(pNP). The cell-seeded scaffolds were allowed to thaw at
room temperature and then were sonicated for roughly
15min. The enzyme reaction was set up by mixing 100mL
of the sample with 300mL of substrate buffer containing
1M diethanolamine HCl (pH 9.8) and 2mg/mL of pNPP.
The solution was incubated at 378C for 1 h, and the reaction
was then stopped by a solution containing 2M NaOH and
0.2mM EDTA in distilled water. The optical density was
determined at 405 nm. A standard curve was made using
pNP values ranging from 0 to 20 mmol/mL. The results are
expressed in micromole of pNP produced/(mL h).
Mineralization content by EDS. The constructs were
processed as described previously for SEM. The samples
were sputter coated with carbon ( JEOL JFC-1100), in order
to verify the presence of calcium and phosphate elements
with a Leica Cambridge S360 electronic microscope.
Statistical analysis
Statistical evaluation was performed using two-tailed
paired Student’s t-tests to assess the statistical differences
between each two groups of different time points. Statistical




The mechanical properties (compressive modulus) of the
developed scaffolds are presented in Table 1. The com-
pressive modulus of the thermally produced scaffolds is in
the range of the trabecular bone modulus.36
Scaffolds with higher and lower compressive modulus
are the ones obtained using the blends chitosan–PBS and
chitosan–PBTA, respectively. These results are in accor-
dance with previous results obtained with compact injection
molded samples.30
Representative mCT images of the entire scaffolds (300
slices) are shown in Figure 1. Three-dimensional recon-
structions of the bulk of the scaffolds were also performed.
No significant differences in terms of morphology were ob-
served between the more interior parts (bulk) of the scaffolds
and the most exterior ones. Two-dimensional X-ray mCT
images, with a region of interest of 4.5!4.5mm, were also
analyzed (figure not shown).
No significant morphological differences were observed
between scaffolds produced using different chitosan-based
blends. Pores resulting from the leaching of the NaCl par-
ticles mimic the cubic shape of the porogen used. The scaf-
folds have a very narrow distribution of pores dimensions
coincident with the NaCl particles size. Two-dimensional
binary images were analyzed for total porosity calculations.
The porosity values presented in Table 1 are the average of
the individual porosity of 300 slices per scaffold. For each
processing condition, four scaffolds were analyzed. As ex-
pected, porosity depended on the amount of porogen used. In
all the cases the porosity was very similar to the amount of
salt used.
In vitro cytotoxicity tests
In the MTS test (Fig. 2), L929 cells produced large
amounts of the brown formazan product after incubation
with the tested extract. This fact shows that cells had similar
metabolic activities (about 80%) to those obtained by the
negative control and were able to incorporate and metabo-
lize MTS, and hence showed their viability. Therefore, the
TABLE 1. COMPRESSIVE MODULUSAND POROSITYOFTHE 50WT.%
CHITOSAN-BASED SCAFFOLDS PRODUCED BY MELT-BASED
COMPRESSION MOLDING WITH SALT LEACHING (60% SALT AND
GRANULOMETRY OF 250–500 mM)
Composition Compressive modulus (MPa) Porosity (%)
50Ch-50PBS 87.4$ 21.6 59.9$ 6.5
50Ch-50PCL 53.1$ 23.7 63.9$ 0.7
50C/50PBTA 21.8$ 7.8 59.4$ 3.8
FIG. 1. Representative 3D mCT image of the scaffolds obtained
using chitosan-based blends and NaCl particles with size 250–
500 mm.
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leachables released from the tested scaffolds could be con-
sidered as noncytotoxic.
Cell adhesion and morphology by SEM
Regarding the present experiment, SEM observations al-
lowed to determine that mouse MSCs were able to adhere to
the surface of the chitosan–polyester–based scaffolds, where
a monolayer of cells could be observed after 1 week in
culture (Fig. 3A–C). Further, it should be highlighted that
there was no pore occlusion by the cells (Fig. 3D), which
demonstrated the adequacy of the pore size range within the
scaffolds (250–500 mm).
By week 2 it was possible to observe a higher degree of
colonization, denoting a multilayer of cells and the onset
of elaboration of extracellular matrix (ECM), at the surface
of all the scaffolds obtained from different chitosan-based
blends (Fig. 3E and F). A closer observation demonstrated
that in the blend composed by chitosan and PBS, there was
a higher degree of proliferation of the cells, including the ones
in the inner regions of the scaffolds (Fig. 3G). Further, by
observing the inside scaffold’s inner regions (Fig. 4) it was
shown that the cells were also capable of colonizing these
areas, without occluding the pores of the scaffolds structure.
After 3 weeks, further development of the cell number and
surfacedensitywereobserved, indicating that theBMC9cells
massively adhered and proliferated within all the chitosan-
based scaffolds, also showing a calcified ECM elaboration
(Fig. 8).
The scaffolds composed by chitosan–PBS showed cell
adhesion and colonization of the surface and inner regions
(Fig. 4), and simultaneously evidencing the elaboration of a
mineralized extracellular matrix, shown by the presence of
Ca and P, by EDS analysis (Fig. 8A).
Cell viability by MTS assay/calcein AM staining
Tracking the survival/activity of the cells seeded on the
scaffolds from the time of seeding until implantation might
be helpful for the optimization on the development of bone
tissue-engineered constructs.37
FIG. 2. Cytotoxicity results of the 72 h extracts of the chitosan–
PBS, chitosan–PCL, and chitosan–PBTAscaffolds.Results are based
on optical density measurements, at OD of 490 nm and normalized
for the negative control (n¼ 6;$ SD; p< 0.05).
FIG. 3. SEM micrographs of BMC9 cells adhesion and proliferation, under osteogenic stimulation, on the 50wt.% chitosan–PBS
scaffolds after (A) 1, (B) 2, and (C) 3 weeks of culture; on the 50wt.% chitosan–PCL scaffolds after (D) 1, (E) 2, and (F) 3 weeks of
culture; and on the 50wt.% chitosan–PCL scaffolds after (G) 1, (H) 2, and (I) 3 weeks of culture.
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Results showed that the tested MSCs were able to reduce
MTS, showing increasing metabolic rates with increasing
time of culture (Fig. 5), and denoting a high viability and
proliferation profile. Cell viability assay with calcein AM
staining (Fig. 6A–C) confirmed the SEM results, where
BMC9 cells were metabolically active in the scaffolds after
3 weeks in static culture. Moreover, with these results it can
be established a time-dependent cell proliferation, as it is
notorious the presence of a higher number of cells for the
latest time period.
Alkaline phosphatase quantification
For all tested blends, ALP activity (Fig. 7) increased until
the second week, reflecting probably the early osteogenic
differentiation stage of the MSCs. After this period, ALP
activity decreased, presumably due to the onset of the min-
eralization process,36 denoting in this sense a positive indi-
cation of the transient character of the differentiation of
the cells into the osteogenic lineage. Once more, the best
results were evidenced by the scaffolds produced from the
chitosan–PBS blend, which showed the higher values of the
ALP activity.
Mineralization content by EDS analysis
The EDS analysis of the surface of the seeded and cul-
tured scaffolds with mouse MSCs under osteogenic condi-
tions for 21 days (Fig. 8) detected the presence of Ca and P
elements on the surface, being therefore, a clear indication
of the formation of a mineralized ECM.
DISCUSSION
In the last few years, natural-based polymers have been
presented as biomaterials for tissue-engineered scaffolding.
Among these, chitosan has emerged as one of the most
promising, namely, by its biodegradability, its biocompati-
bility, and its resemblance to glycosaminoglycans.28
In this study we report the biological performance, in
terms of cell adhesion, proliferation, and differentiation of
mouse MSCs seeded and cultured onto the newly devel-
oped chitosan-based scaffolds.
The melt-based approach used to produce the scaffolds
allowed us to obtain 3D porous structures without the use
of organic solvents that could remain in the structure and
damage the transplanted cells or the surrounding tissues
(after transplantation). The mechanical properties, in terms
of compressive modulus, were in the range of those for
trabecular bone properties.36
The developed scaffolds revealed to be noncytotoxic to
fibroblast cells, since the leachables released during the
extraction period did not affect cell viability and did not
inflict changes in cell morphology.
Cells were able to colonize the scaffolds structure up to 3
weeks. The cell proliferation was gradual and continuously
increasing over time of culture, being more evident on the
chitosan–PBSscaffolds. The differences observed for the dif-
ferent blends are probably related with the different surface
chemistry and mechanical properties of the 3D scaffolds,
with the best results being noticed for the scaffolds pro-
duced from chitosan–PBS blend.
It is known that if cells are undergoing osteogenic dif-
ferentiation, ALP is considered to be one of the early
markers.38 Although not being specific for the osteoblast
lineage, ALP is used typically to illustrate the early differ-
entiation into a bone-related phenotype, which is noticed by
the increase of the enzyme activity until the second week.
The presence of Ca and P elements on the surface of the
cell-seeded scaffolds revealed the presence of a mineralized
ECM. This fact is in agreement with the data obtained for
alkaline phosphatase experiments, showing that cells had
undergone an osteogenic differentiation and were elabo-
rating mineralized ECM.
FIG. 4. Light micrograph illustrating a representative section of
the colonization of the MSCs onto the chitosan–PBS scaffolds for
21 days, after H&E staining. Original magnification 100!. Color
images available online at www.liebertpub.com/ten.
FIG. 5. Viability of the BMC9 cells seeded and cultured onto the
chitosan–PBS (ch–PBS), chitosan–PCL (ch–PCL), and chitosan–
PBTA (ch–PBTA) scaffolds following 3 h after cell seeding, at 1,
2, and 3 weeks, by MTS assay (n¼ 6;$ SD; p< 0.05).
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CONCLUSIONS
With the present study it was possible to show that the
scaffolds based on 50:50wt.% blends of chitosan and syn-
thetic polyesters (PBS, PCL, and PBTA) present a range of
properties that are considered to be adequate for bone tissue
engineering applications.
Scaffolds produced by compression molding followed by
salt leaching were shown to be noncytotoxic and clearly
cytocompatible. The results of the direct contact assays
under osteogenic conditions revealed that the three types of
chitosan-based scaffolds selected for this study promoted the
attachment and proliferation of mouse mesenchymal stem
cells. Further, they also presented high indexes of alkaline
phosphatase activity and the production of a calcified ECM,
which is due to the differentiation toward the osteogenic
pathway. From the three tested blends, the chitosan–PBS
blend showed the best results, namely, in terms of cell ad-
hesion and proliferation. Nevertheless, the other blends also
presented adequate properties for bone tissue engineering.
Due to the good combination of properties and excellent
biological performance, it is strongly believed that the scaf-
folds herein proposed will be a valid alternative to the cur-
rently used materials when considering bone regeneration/
tissue engineering applications.
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